Back

Validation of CHA2DS2-VA score (excluding female sex) in non-valvular atrial fibrillation patients: a nationwide population-based study

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Epidemiology of atrial fibrillation Stroke Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Jooyoung Woo

Busan (Korea (Republic of))

19 More presentations in this session

Presentation thumbnail
Doctor M. Nakano (Chiba, JP)
Abstract
Presentation thumbnail
Doctor H. Fujimoto (Nara, JP)
Abstract Slides
Presentation thumbnail
Doctor T. Gizatulina (Tyumen, RU)
Abstract Slides
Presentation thumbnail
Doctor N. Tanaka (Osaka, JP)
Abstract Slides
Presentation thumbnail
Doctor M. Baturova (Saint Petersburg, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Epidemiology of atrial fibrillation

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
16 April 2023
thumbnail
Congress Presentation
Sex differences in the use of rhythm control strategies in patients with atrial fibrillation in FinACAF study
29 August 2022
thumbnail
Congress Presentation
Comparison of SCORE and SCORE 2 model for cardiovascular risk stratification in men and women from high risk European country
13 April 2023
thumbnail
Congress Presentation
Refining the CHA2DS2VASc risk stratification scheme: Shall we drop the Sex Category?
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources